In our model of acute HP, the administration of the anti-IL-17A antibody decreased the formation of granulomata and the ratio of neutrophils in the BAL fluids, and decreased the expression level of CXCL5 in the lungs. Here, IL17A is linked to hypersensitivity pneumonitis.